In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Arbutus Biopharma Corporation

http://arbutusbio.com/

Latest From Arbutus Biopharma Corporation

Antios Raises $96m To Advance HBV Drug With Pharmasset Pedigree

Antios thinks ATI-2173, which employs the Pharmasset liver-targeting chemistry used in HCV blockbuster Sovaldi, can help produce a functional cure in hepatitis B combination therapy.

Financing Business Strategies

SeaSpine Holdings Acquires Toronto-Based 7D Surgical For $110M

BTIG analyst expects SeaSpine’s acquisition of 7D Systems will help SeaSpine morph into a procedurally integrated solutions provider.

Deals M & A

Henlius’ Ophthalmic Bevacizumab Program Moves Ahead

Shanghai Henlius Biotech is planning to move forward with wet AMD trials for its bevacizumab biosimilar rival to Avastin following a nod from the US FDA.

Biosimilars Clinical Trials

Pfizer Throws In China Biosimilar Towel, Divests Site To WuXi

After an earlier frenzy around local production and supply, policies to encourage generics, and fast-evolving procedural streamlining, Pfizer’s $350m ambition to develop and make cheaper biologics in China has come to an abrupt halt with the sale of its manufacturing site in a deal with services heavyweight WuXi Apptec.

Biosimilars China
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
    • Liposomes
    • Nanotechnology, Chips, etc.
  • Other Names / Subsidiaries
    • Genevant Sciences
    • Inex Pharmaceuticals Corporation
    • OnCore Biopharma, Inc, (Enantigen Therapeutics, Inc.)
    • Tekmira Pharmaceuticals Corporation (TKMR)
    • Protiva Biotherapeutics Inc.
UsernamePublicRestriction

Register